Sionna Therapeutics competitors

View the competitive landscape for Sionna Therapeutics, featuring companies like AbbVie, Vertex Pharmaceuticals, and Eloxx Pharmaceuticals. Mapping a different industry? Browse our competitor database or generate a competitor list for any company.

Company icon
Sionna Therapeutics

Clinical-stage biopharmaceutical company developing small molecule cystic fibrosis treatments

sionnatx.com

List of Sionna Therapeutics competitors

  • Company icon

    AbbVie

    Biopharmaceutical company developing various therapeutic treatments including cystic fibrosis modulators

    abbvie.com
  • Company icon

    Vertex Pharmaceuticals

    Biopharmaceutical company specializing in CFTR modulator therapies for cystic fibrosis

    vrtx.com
  • Company icon

    Eloxx Pharmaceuticals

    Clinical-stage biopharmaceutical company focusing on ribosomal RNA-targeted genetic medicines

    eloxxpharma.com
  • Company icon

    Enterprise Therapeutics

    Biotechnology company developing novel therapies for muco-obstructive respiratory diseases

    enterprisetherapeutics.com
  • Company icon

    4D Molecular Therapeutics

    Clinical-stage company developing targeted genetic medicines for respiratory conditions

    4dmoleculartherapeutics.com
  • Company icon

    ReCode Therapeutics

    Genetic medicines company developing mRNA-based therapies for cystic fibrosis

    recodetx.com
  • Company icon

    Spirovant

    Gene therapy company developing treatments for cystic fibrosis and respiratory diseases

    spirovant.com
  • Company icon

    SpliSense

    Biotechnology company developing RNA therapies for genetic pulmonary diseases

    splisense.com
  • Company icon

    Kither Biotech

    Biopharmaceutical company developing pulmonary therapies for cystic fibrosis and asthma

    kitherbiotech.com
  • Company icon

    Arcturus Therapeutics

    Clinical-stage mRNA medicines company targeting cystic fibrosis and rare diseases

    arcturustx.com
Track Sionna Therapeutics & Its Competitors

Follow their latest moves with a real-time news feed and summaries delivered straight to your inbox.